Price
$284.39+2.66%1Y
1M+2.30%1Y+2.66%
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Below average4/10
Value42
Quality68
Momentum27
Growth39
P/E (TTM)23.2
Market Cap$20.98B
1Y Return+2.66%
5Y Return+25.37%
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Q1 2026Total $3.54B (-0.73%)
●Biopharma Laboratory Services grew +8.22% YoY●Diagnostics +5.04% YoY
SegmentLatestQoQYoY
- Diagnostics$2.76B-0.27%+5.04%
- Biopharma Laboratory Services$780.6M-2.32%+8.22%
- Covance Drug Development---
- Drug Development---
- Lab Corp Diagnostics---